Developmental Funds have been used to support pilot research projects, new faculty, new shared resources, research in familial cancers, and development of new physician scientists. In the current CCSG funding period, $2.4 million was allocated to support new faculty and research, with $973,000 coming from the CCSG consisting of $400,000 of Developmental Funds, and $573,000 in CCSG supplements for the development of breast cancer research (year 17) and for cancer prevention and control (for years 17-20). In addition, there was $294,000 (years 17-20) in development funds from the American Cancer Society (ACS) and $1.01 million from Director?s discretionary funds. Allocation of funds is at the discretion of the NCCC Director with recommendations by the Center Leadership and Cancer Research Committee. In the current application, $100,000 is requested for funding pilot projects and $125,000 to fund new faculty for an overall budget of $225,000. No funds are requested for development of shared resources in this application.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-24
Application #
6573843
Study Section
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
24
Fiscal Year
2002
Total Cost
$248,412
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Lin, Anping; Yin, Juan; Cheng, Chao et al. (2018) Decreased expression of FOXA2 promotes eutopic endometrial cell proliferation and migration in patients with endometriosis. Reprod Biomed Online 36:181-187
Elder, David E; Piepkorn, Michael W; Barnhill, Raymond L et al. (2018) Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation. J Am Acad Dermatol 79:52-59.e5
Rutter, Carolyn M; Kim, Jane J; Meester, Reinier G S et al. (2018) Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev 27:158-164
Kumar, Nishant; Tafe, Laura J; Higgins, John H et al. (2018) Identifying Associations between Somatic Mutations and Clinicopathologic Findings in Lung Cancer Pathology Reports. Methods Inf Med 57:63-73
Punshon, Tracy; Jackson, Brian P (2018) Essential micronutrient and toxic trace element concentrations in gluten containing and gluten-free foods. Food Chem 252:258-264
Pernas, Sonia; Martin, Miguel; Kaufman, Peter A et al. (2018) Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial. Lancet Oncol 19:812-824
Svedbom, Axel; Borgström, Fredrik; Hernlund, Emma et al. (2018) Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS. Qual Life Res 27:707-716
Skolasky, Richard L; Scherer, Emily A; Wegener, Stephen T et al. (2018) Does reduction in sciatica symptoms precede improvement in disability and physical health among those treated surgically for intervertebral disc herniation? Analysis of temporal patterns in data from the Spine Patient Outcomes Research Trial. Spine J 18:1318-1324
Doubeni, Chyke A; Gabler, Nicole B; Wheeler, Cosette M et al. (2018) Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin 68:199-216
Sites, Brian D; Harrison, Jordon; Herrick, Michael D et al. (2018) Prescription Opioid Use and Satisfaction With Care Among Adults With Musculoskeletal Conditions. Ann Fam Med 16:6-13

Showing the most recent 10 out of 1911 publications